Phibro Animal Health Management
Management criteria checks 4/4
Phibro Animal Health's CEO is Jack Bendheim, appointed in Jan 1988, has a tenure of 36.25 years. total yearly compensation is $2.94M, comprised of 77.2% salary and 22.8% bonuses, including company stock and options. directly owns 49.94% of the company’s shares, worth $251.61M. The average tenure of the management team and the board of directors is 6.5 years and 14.8 years respectively.
Key information
Jack Bendheim
Chief executive officer
US$2.9m
Total compensation
| CEO salary percentage | 77.2% |
| CEO tenure | 36.3yrs |
| CEO ownership | 49.9% |
| Management average tenure | 6.5yrs |
| Board average tenure | 14.8yrs |
Recent management updates
Recent updates
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10
Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
Jul 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$15m |
| Sep 30 2023 | n/a | n/a | US$21m |
| Jun 30 2023 | US$3m | US$2m | US$33m |
| Mar 31 2023 | n/a | n/a | US$29m |
| Dec 31 2022 | n/a | n/a | US$36m |
| Sep 30 2022 | n/a | n/a | US$46m |
| Jun 30 2022 | US$4m | US$2m | US$49m |
| Mar 31 2022 | n/a | n/a | US$59m |
| Dec 31 2021 | n/a | n/a | US$53m |
| Sep 30 2021 | n/a | n/a | US$49m |
| Jun 30 2021 | US$4m | US$2m | US$54m |
| Mar 31 2021 | n/a | n/a | US$43m |
| Dec 31 2020 | n/a | n/a | US$44m |
| Sep 30 2020 | n/a | n/a | US$43m |
| Jun 30 2020 | US$3m | US$2m | US$34m |
| Mar 31 2020 | n/a | n/a | US$37m |
| Dec 31 2019 | n/a | n/a | US$38m |
| Sep 30 2019 | n/a | n/a | US$41m |
| Jun 30 2019 | US$3m | US$2m | US$55m |
| Mar 31 2019 | n/a | n/a | US$68m |
| Dec 31 2018 | n/a | n/a | US$73m |
| Sep 30 2018 | n/a | n/a | US$65m |
| Jun 30 2018 | US$3m | US$2m | US$65m |
| Mar 31 2018 | n/a | n/a | US$58m |
| Dec 31 2017 | n/a | n/a | US$62m |
| Sep 30 2017 | n/a | n/a | US$68m |
| Jun 30 2017 | US$3m | US$2m | US$65m |
Compensation vs Market: Jack's total compensation ($USD2.94M) is about average for companies of similar size in the US market ($USD2.37M).
Compensation vs Earnings: Jack's compensation has been consistent with company performance over the past year.
CEO
Jack Bendheim (76 yo)
36.3yrs
Tenure
US$2,938,899
Compensation
Mr. Jack Clifford Bendheim has been the President and Chief Executive Officer of Phibro Animal Health Corporation since 1988 and March 2014, respectively and serves as its Chairman. Mr. Bendheim served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 36.3yrs | US$2.94m | 49.94% $ 251.6m | |
| Chief Operating Officer | 7.8yrs | US$778.80k | 0.074% $ 373.2k | |
| Executive VP of Corporate Strategy & Director | 10.1yrs | US$554.69k | no data | |
| President of North America Region | 4.9yrs | US$619.27k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior VP | less than a year | no data | no data | |
| Senior Vice President of Human Resources | 7.1yrs | no data | no data | |
| President of MACIE Region | no data | no data | no data | |
| President South America Region | 6.8yrs | no data | no data | |
| President of Asia Pacific Region | less than a year | no data | no data | |
| President of PhibroChem and Ethanol Performance Group | no data | no data | no data | |
| VP of Finance & Treasurer | 6.1yrs | no data | no data |
6.5yrs
Average Tenure
54yo
Average Age
Experienced Management: PAHC's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 40.3yrs | US$2.94m | 49.94% $ 251.6m | |
| Executive VP of Corporate Strategy & Director | 10.4yrs | US$554.69k | no data | |
| President of MACIE Region | 5.7yrs | no data | no data | |
| Independent Non-Executive Director | 20.3yrs | US$60.00k | no data | |
| Independent Non Executive Director | 19.9yrs | US$40.00k | no data | |
| Independent Director | 13.8yrs | US$60.00k | 0.0025% $ 12.4k | |
| Independent Non-Executive Director | 15.9yrs | US$50.00k | 0.049% $ 248.8k | |
| Independent Director | 1.2yrs | US$22.50k | no data |
14.8yrs
Average Tenure
64yo
Average Age
Experienced Board: PAHC's board of directors are seasoned and experienced ( 14.8 years average tenure).